Cogent Biosciences, Inc. (COGT)

Cogent Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	825	506	808	342	127	22
Market Cap Growth	-7.48%	-37.32%	136.30%	168.44%	476.79%	-83.26%
Enterprise Value	406	260	567	124	-111	-11
PE Ratio	-	-2.63	-5.76	-4.73	-0.71	-0.69
PS Ratio	-	-	-	-	16.18	0.98
PB Ratio	1.95	1.96	3.16	1.60	0.54	0.70
P/FCF Ratio	-4.15	-3.24	-6.44	-5.65	-3.59	-0.53
P/OCF Ratio	-4.19	-3.30	-6.81	-5.82	-3.55	-0.53
EV/Sales Ratio	-	-	-	-	-14.08	-0.47
EV/EBITDA Ratio	-1.35	-1.37	-4.22	-1.77	1.50	0.35
EV/EBIT Ratio	-1.32	-1.35	-4.04	-1.72	1.48	0.33
EV/FCF Ratio	-1.67	-1.66	-4.52	-2.05	3.12	0.26
Debt / Equity Ratio	0.04	0.07	0.08	0.01	0.02	0.19
Debt / EBITDA Ratio	-0.09	-0.10	-0.15	-0.04	-0.07	-0.20
Debt / FCF Ratio	-0.11	-0.12	-0.16	-0.05	-0.15	-0.15
Quick Ratio	11.88	6.96	9.70	12.94	18.59	3.07
Current Ratio	12.05	7.09	9.87	13.04	18.70	3.06
Asset Turnover	0	0	0	0	0.07	0.35
Return on Equity (ROE)	-63.70%	-67.90%	-53.30%	-34.00%	-278.50%	-85.20%
Return on Assets (ROA)	-55.20%	-58.10%	-46.50%	-31.60%	-155.60%	-49.40%
Return on Capital (ROIC)	-51.56%	-75.23%	-53.68%	-34.76%	-34.27%	-85.14%
Earnings Yield	-25.77%	-37.99%	-17.36%	-21.14%	-140.69%	-144.15%
FCF Yield	-20.46%	-30.89%	-15.53%	-17.69%	-27.89%	-187.21%
Buyback Yield / Dilution	-34.03%	-35.61%	-51.66%	-249.52%	-45.42%	-22.43%
Total Shareholder Return	-34.03%	-35.61%	-51.66%	-249.52%	-45.42%	-22.43%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).